SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Fuji (FUJIY)
FUJIY 11.59+0.3%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: zax4/14/2020 11:58:46 AM
   of 12
 
Fujifilm to Start Clinical Trial of Avigan in U.S.

Fujifilm Holdings Corp. said Thursday that it will conduct a clinical trial in the U.S. to evaluate the safety and efficacy of its flu drug Avigan for patients with Covid-19.

The Japanese chemical company said the clinical trial will enroll about 50 patients with Covid-19 at three Massachusetts facilities: Brigham and Women's Hospital, Massachusetts General Hospital and the University of Massachusetts Medical School.

In Japan, a nationwide Avigan trial began several weeks ago.

Avigan hasn't been used in Japan for regular flu because studies in monkeys, rabbits and mice suggested that if a pregnant woman took the drug, it could cause deformities in the fetus or kill the fetus.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext